Legal & General Group
MANE

Legal & General Group’s Veradermics Inc MANE Stock Holding History

Legal & General Group’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
15,480
+8,375
+118% +$785K ﹤0.01% 1985
2026
Q1 		$449K Buy
+7,105
New +$358K ﹤0.01% 2380

Other funds holding MANE

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Legal & General Group's MANE Position: Q2 2026 in Review

Legal & General Group increased its Veradermics Inc (MANE) stake by 118% in Q2 2026, buying an estimated $785K and bringing the position to 15,480 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Legal & General Group first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Legal & General Group held 15,480 shares of Veradermics Inc worth $1.9M as of Q2 2026.
  • Legal & General Group bought 8,375 Veradermics Inc shares in Q2 2026, an estimated $785K.
  • Veradermics Inc made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1985 holding.
  • Legal & General Group first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.